Phase
Condition
Allergy
Hereditary Angioedema
Allergies & Asthma
Treatment
rhC1INH or pdC1INH
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Decision to treat the HAE patient with C1 inhibitor (either Ruconest or pdC1INH)
Patients must give written informed consent
Exclusion
Exclusion Criteria:
- A diagnosis of acquired C1INH deficiency (AAE)
Study Design
Study Description
Connect with a study center
UMHAT Alexandrovska EAD
Sofia,
BulgariaSite Not Available
KBC Split
Split,
CroatiaSite Not Available
CHC Sestre milosrdnice
Zagreb,
CroatiaSite Not Available
General Hospital Sibenik
Šibenik,
CroatiaSite Not Available
Faculty Hospital by St. Anna Brno
Brno,
Czech RepublicSite Not Available
Faculty Hospital by St. Anna Brno
Brno,
CzechiaActive - Recruiting
Hospital A Michallon, CHU Grenoble
La Tronche,
FranceSite Not Available
Charite Universitatsmedizin Berlin
Berlin,
GermanySite Not Available
Semmelweis University, 3rd Department of Internal Medicine
Budapest,
HungarySite Not Available
Ospedale Luigi Sacco
Milan,
ItalySite Not Available
PHI University Clinic of Dermatology
Skopje,
Macedonia, The Former Yugoslav Republic ofSite Not Available
For information on sites in Europe, please contact Pharming Technologies
Leiden, 2333 CR
NetherlandsSite Not Available
PHI University Clinic of Dermatology
Skopje,
North MacedoniaActive - Recruiting
Alesund Hospital
Alesund,
NorwaySite Not Available
Stavanger University Hospital
Stavanger,
NorwaySite Not Available
University Hospital Krakow
Krakow,
PolandSite Not Available
Bratislava University Hospital
Bratislava,
SlovakiaSite Not Available
University Hospital Martin
Martin,
SlovakiaSite Not Available
University Clinic Golnik
Golnik,
SloveniaSite Not Available
Ryhof County Hospital
Jonkoping,
SwedenSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.